Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15197804rdf:typepubmed:Citationlld:pubmed
pubmed-article:15197804lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0521324lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0280100lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0257685lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:15197804lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:15197804pubmed:issue12lld:pubmed
pubmed-article:15197804pubmed:dateCreated2004-6-15lld:pubmed
pubmed-article:15197804pubmed:abstractTextThe authors previously reported the efficacy of a dose of 4 mg of zoledronic acid in reducing skeletal complications in patients with bone metastases secondary to lung carcinoma and other solid tumors (except carcinomas of the breast and prostate). In the current study, they update these results and report the long-term efficacy and safety of 21 months of treatment with zoledronic acid in a randomized, placebo-controlled trial.lld:pubmed
pubmed-article:15197804pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15197804pubmed:languageenglld:pubmed
pubmed-article:15197804pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15197804pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15197804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15197804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15197804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15197804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15197804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15197804pubmed:statusMEDLINElld:pubmed
pubmed-article:15197804pubmed:monthJunlld:pubmed
pubmed-article:15197804pubmed:issn0008-543Xlld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:KrzakowskiMac...lld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:ZhengMingMlld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:GordonDavidDlld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:RosenLee SLSlld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:TchekmedyianN...lld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:SeamanJohnJlld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:HirshVeraVlld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:ReitsmaDirkDlld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:YanagiharaRon...lld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:UrbanowitzGla...lld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:PawlickiMarek...lld:pubmed
pubmed-article:15197804pubmed:authorpubmed-author:De SouzaPaulPlld:pubmed
pubmed-article:15197804pubmed:copyrightInfoCopyright 2004 American Cancer Society.lld:pubmed
pubmed-article:15197804pubmed:issnTypePrintlld:pubmed
pubmed-article:15197804pubmed:day15lld:pubmed
pubmed-article:15197804pubmed:volume100lld:pubmed
pubmed-article:15197804pubmed:ownerNLMlld:pubmed
pubmed-article:15197804pubmed:authorsCompleteYlld:pubmed
pubmed-article:15197804pubmed:pagination2613-21lld:pubmed
pubmed-article:15197804pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:meshHeadingpubmed-meshheading:15197804...lld:pubmed
pubmed-article:15197804pubmed:year2004lld:pubmed
pubmed-article:15197804pubmed:articleTitleLong-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.lld:pubmed
pubmed-article:15197804pubmed:affiliationDevelopmental Therapeutics, Cancer Institute Medical Group, Los Angeles, California 90025, USA. lrosen@targenix.comlld:pubmed
pubmed-article:15197804pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15197804pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15197804pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15197804pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15197804pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15197804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15197804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15197804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15197804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15197804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15197804lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15197804lld:pubmed